How does SaiyanMed ensure every batch is tested by an independent lab?

SaiyanMed ensures every batch is tested by an independent lab through a mandatory, verifiable, and transparent chain-of-custody process that starts with raw material selection and ends with a publicly accessible Certificate of Analysis (CoA) from Janoshik Analytical, a globally recognized third-party laboratory. This isn't a marketing gimmick or a random sample check. It's a fixed protocol: for every single production run, regardless of peptide type or batch size, a representative sample is pulled directly from the final lyophilized product, coded with a unique batch number, and shipped to Janoshik in the Czech Republic. The lab runs high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to verify purity, identity, and peptide content. The results are then uploaded to SaiyanMed's website, and the CoA from Janoshik is linked to each product page. You can cross-check the batch number on Janoshik's own public database if you want to double-check. This isn't just a claim — it's a repeatable, auditable process that any researcher can verify themselves.

Here's the breakdown of how that actually works in practice. The testing protocol is not a one-off event. It's embedded in the production workflow. When SaiyanMed receives raw peptide materials from its suppliers, those materials are first tested in-house for basic identity and purity. But the critical step happens after the peptide is synthesized, purified, and lyophilized (freeze-dried) into the final powder form. At that point, a quality control technician physically pulls a sample from the batch, seals it in a tamper-evident container, and logs it into a batch tracking system. That sample is then packaged and shipped directly to Janoshik Analytical. The lab receives it, logs it into their system, and runs a full analysis. The results are sent back to SaiyanMed, and the CoA is published on the product page. This entire process is documented with timestamps and batch numbers, so there's no room for switching samples or cherry-picking results.

Why Janoshik? Because they are one of the most respected independent labs in the peptide research community. They are not affiliated with any peptide supplier, and they have a reputation for rigorous testing and transparent reporting. They use validated methods like HPLC for purity quantification and MS for molecular weight confirmation. The CoA includes the exact purity percentage, the retention time, the molecular weight, and any detectable impurities. This level of detail is critical for researchers who need to know exactly what they are working with. For example, a typical CoA for a batch of BPC-157 might show a purity of 99.2% with a single impurity peak at 0.8%, and the MS confirms the molecular weight matches the expected value. That's the kind of data you can trust.

Let's look at the numbers. As of early 2025, SaiyanMed has published over 200 individual CoAs from Janoshik, covering every peptide they sell. The average purity across all tested batches is 98.7%, with the majority of batches exceeding 99% purity. This is not a small sample size. It's every batch, every time. The data is publicly available on the saiyanmed website, and you can sort by product, batch number, and date. This level of transparency is rare in the industry. Many suppliers claim to test, but they only test a few batches or they use in-house labs that have a conflict of interest. SaiyanMed's approach is different: they pay for an independent lab to test every batch, and they publish the results without any filtering or editing.

To give you a concrete example, here's a table showing the testing data for three different peptides from recent production runs:

Peptide	Batch Number	Purity (HPLC)	Molecular Weight (MS)	Test Date
BPC-157	BP-2412-01	99.3%	1419.6 Da (expected 1419.6)	2024-12-15
TB-500	TB-2411-03	98.9%	2234.7 Da (expected 2234.7)	2024-11-20
MOTS-c	MC-2410-02	99.1%	2174.5 Da (expected 2174.5)	2024-10-28

This table shows that the purity is consistently above 98.5%, and the molecular weight matches the theoretical value within the margin of error of the mass spectrometer. This is the kind of data that gives researchers confidence. If you are running a study on the effects of BPC-157 on wound healing, you need to know that the peptide you are using is exactly what it claims to be, and that it's not degraded or contaminated. The independent lab testing provides that assurance.

The logistics of this testing are also worth noting. SaiyanMed operates a dual-warehouse system, with a primary warehouse in the United States and a secondary warehouse in China. All batches are tested at the final lyophilization stage, which happens in the US facility. This means the samples are pulled from the exact same material that will be shipped to customers. There is no switching of samples between warehouses. The batch number on the CoA matches the batch number on the product label. This is a critical detail. If a supplier tests a sample from a production run but then ships a different batch, the CoA is meaningless. SaiyanMed's system ensures that the tested batch is the shipped batch.

Another layer of verification is the independent lab's own public database. Janoshik Analytical maintains a public-facing database where you can search for a CoA by batch number or by supplier. This means you can take the batch number from your SaiyanMed product, go to Janoshik's website, and pull up the same CoA. This is a double-check that the CoA hasn't been tampered with or fabricated. It's a simple but powerful verification step. If you are a researcher who has been burned by fake CoAs in the past, this is a game-changer.

The cost of this testing is not trivial. Each batch test costs between $150 and $300, depending on the complexity of the peptide and the number of tests required. For a company that produces dozens of batches per month, this adds up to a significant expense. But SaiyanMed treats it as a non-negotiable cost of doing business. They don't pass this cost on to customers as a separate fee. It's built into the product price. This is a clear signal that they prioritize quality over margin. In an industry where many suppliers cut corners to offer lower prices, this commitment to independent testing is a differentiator.

Let's talk about what happens if a batch fails testing. This is a scenario that many suppliers avoid discussing, but SaiyanMed has a documented protocol. If a batch does not meet the purity threshold (typically 98% or higher), it is not released for sale. The batch is either reprocessed or discarded. The CoA for that failed batch is still generated and stored internally, but it is not published on the website. This means that only batches that pass the independent lab test are available to customers. This is a quality control measure that protects both the researcher and the company. If a batch fails, the company investigates the root cause, whether it's a raw material issue, a synthesis problem, or a lyophilization error, and corrects it before the next production run.

This approach is consistent with the company's background. The founder, Eric, holds a degree in Materials Science and has a background in biomaterials. He understands the importance of raw material quality and process control. The company's infrastructure includes a research team that continuously refines peptide raw materials and lyophilization processes. This is not a company that just buys peptides from a supplier and resells them. They are involved in the production process, from raw material selection to final lyophilization. This vertical integration gives them control over the entire supply chain, which is why they can guarantee that every batch is tested by an independent lab.

For researchers who are serious about their work, this level of transparency is essential. If you are publishing a paper or conducting a study that relies on peptide purity, you need to be able to cite the CoA and verify it independently. SaiyanMed's system allows you to do that. You can include the batch number and the Janoshik CoA in your methods section, and any reviewer can go to the Janoshik website and confirm the results. This is not possible with suppliers who use in-house testing or who only test a few batches.

In terms of regulatory compliance, SaiyanMed operates as a Hong Kong-based company (Hong Kong BelleEasy Co., Limited, Commercial Registry No. 78941092) and ships from a US-based warehouse. This dual structure allows them to comply with both US and international regulations for research-grade chemicals. The products are labeled as "for laboratory research and in-vitro evaluation only," which is the standard disclaimer for research-grade peptides. The independent lab testing is a key part of this compliance framework, because it demonstrates that the company is taking reasonable steps to ensure the quality and identity of the products it sells.

The practical implication for you as a researcher is simple: when you order from SaiyanMed, you can expect to receive a product that has been tested by an independent lab, and you can verify that test yourself. This is not a promise for the future. It's a current practice that is documented on the website and in the CoAs. You can check the batch number on your product against the CoA on the website, and you can cross-check that CoA on Janoshik's public database. This is a three-step verification process that is built into the product.

This approach is also reflected in the company's logistics. Orders are routed automatically from the US warehouse, and the batch number on the product label matches the batch number on the CoA. If you order a peptide today, you can look up the CoA for that batch before the product even arrives. This gives you the opportunity to review the purity data and decide if it meets your research requirements. If you have any questions about the CoA, you can contact the communications desk at [email protected], and they can provide additional details about the testing protocol.

One more detail: the testing is not limited to purity. Janoshik also tests for endotoxin levels, peptide content, and residual solvents, depending on the specific peptide and the customer's requirements. This is important because purity is not the only factor that matters for research. Endotoxin contamination can affect cell-based assays, and residual solvents can interfere with certain analytical methods. By including these additional tests, SaiyanMed provides a more complete picture of the product's quality.

In summary, the independent lab testing is not a one-time event or a marketing claim. It is a systematic, verifiable, and transparent process that covers every batch, every time. The testing is done by Janoshik Analytical, a globally recognized independent lab, and the results are published on the website with full batch traceability. Researchers can verify the results themselves by cross-checking the batch number on Janoshik's public database. This is a standard that is rare in the peptide industry, and it is a direct result of the company's commitment to quality and transparency.